Developer docs
API playgroundTry for free, no card

Search company profiles

SeaChange Biochemistry

Full company profile

uuid0005yi4

Namestring
SeaChange Biochemistry
Legal namestring
SeaChange Biochemistry
Company typeenum
Private
Founded yearint
2020
Descriptiontext

SeaChange Biochemistry is a Halifax, Canada-based ingredient biotechnology company founded in 2020 that develops and supplies clinically validated, seaweed-derived bioactive compounds for the wellness, cosmetics, nutraceutical, and functional food and beverage industries. The company operates a proprietary, patent-pending extraction platform called SeaQuence™, which uses green chemistry principles and CO2 freeze drying to sequentially extract polyphenols, fucoidan, beta-glucans, and stem cell activators from organic wild-harvested Nova Scotia seaweed — reportedly eliminating up to 90% of the waste generated by conventional solvent-based extraction methods. Its flagship product brand, PolySea™, is positioned as a clinically proven anti-aging and immune-support ingredient available in three application formats: topicals, supplements, and functional food and beverage ingredients, with future pipeline ingredients including Fucoidan, Alginate, and PolySea™ Bioplastics targeting pharmaceutical and sustainable packaging markets.

The company has completed two human clinical trials through a research partnership with NIS Labs — a 20-participant placebo-controlled, randomized, double-blind, cross-over study for ingestibles and a 60-participant 9-week study for topicals in women aged 30-50 — producing quantifiable claims including 8X antioxidant activity versus leading extracts, 10X antioxidant power versus elderberry, 23% reduction in fine lines, 37% reduction in wrinkles, 48% increase in skin hydration, and rapid immune activation within 1-2 hours of consumption. The business model is primarily B2B enterprise field sales to cosmetics brands, nutraceutical companies, and functional food and beverage manufacturers under quote-based multi-year contracts, supplemented by a direct-to-consumer channel selling finished PolySea products through the company website. The company is founder-led by CEO Sabrena MacKenzie, a marine scientist and biochemist, with 1-10 employees and minimal disclosed external capital (a $25,000 Ocean Startup Project grant in 2020 and an undisclosed follow-on grant in 2021).

Short descriptiontext

SeaChange Biochemistry is a Halifax-based biotech company that extracts clinically validated bioactive compounds from sustainably wild-harvested Nova Scotia seaweed using its proprietary SeaQuence™ green chemistry process, supplying PolySea™ ingredients to cosmetics, nutraceutical, and functional food and beverage brands.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersHalifax, Canada
HQ citystring
Halifax
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
seaweed bioactive extraction, natural ingredient manufacturing, cosmetics ingredient supply, nutraceutical ingredient supply, green chemistry extraction
Industry3 codes
PRIMARYAFAJAMAD
Seaweed Hydrocolloids (Agar, Carrageenan, Alginates)
Agriculture & Food Production/Food Ingredients & Additives/Texturizers (Thickeners & Stabilizers)
SECONDARYAFAJAHAF
Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)
SECONDARYIMANANAD
Compostable & Bio-based Rigid Packaging (injection/blow/thermoform)
Product category
Seaweed-Derived Bioactive Ingredient Manufacturing
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1B2B Bioactive Ingredient Sales
TypeLicensing Royalties
Description

Supply of PolySea™ bioactive ingredients to cosmetics, skincare, nutraceutical, and functional food & beverage manufacturers for use in their products.

seachangebiochemistry.com
2Contract Manufacturing / White-label
TypeLicensing Royalties
Description

Provides clinically proven seaweed bioactives that can be incorporated into partner brand formulations, with B2B partnership model for co-development.

seachangebiochemistry.com
3Finished Product Sales (Direct-to-Consumer)
TypeOne Time License
Description

Sale of PolySea-infused topical and ingestible wellness products directly to consumers through website and potentially retail channels.

seachangebiochemistry.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales
Pricing details1 tier
1B2B ingredient pricing - quote-based
ModelOtherBilling cadenceMulti-year contract
Notes

Custom pricing for bulk bioactive ingredient orders to manufacturers and brands. Sample requests available through contact form.

seachangebiochemistry.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1PolySea™
Description

The company's flagship seaweed-derived bioactive ingredient line, clinically proven for anti-aging, immune support, and skin health benefits.

seachangebiochemistry.com
+1 more record
Core offering1 text field

SeaChange Biochemistry extracts clinically validated bioactive compounds (polyphenols, fucoidan, beta-glucans, stem cell activators) from sustainably wild-harvested Nova Scotia seaweed using its proprietary patent-pending SeaQuence™ green-chemistry process and large-scale CO2 freeze drying. It supplies the resulting PolySea™ bioactive ingredients on a B2B basis to cosmetics/skincare brands, nutraceutical/ supplement manufacturers, and functional food & beverage companies, and also sells PolySea-infused topical and ingestible wellness products direct to consumers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 9 values shown
  • 8X stronger antioxidant activity than leading extracts
+8 more records
Product overview1 text field

SeaChange Biochemistry offers PolySea™ as its core bioactive ingredient brand derived from organic wild-harvested Nova Scotia seaweed. The product portfolio spans three main application formats: PolySea™ Topicals (advanced skincare), PolySea™ Supplements (cellular wellness and immune support), and PolySea™ Functional Food & Beverages (nutritional applications). The proprietary SeaQuence™ Process serves as the extraction and manufacturing platform enabling all product lines. Future pipeline ingredients include Fucoidan, Alginate, and Bioplastics. All products are positioned for B2B wellness partners including cosmetic brands, nutraceutical companies, and functional food manufacturers.

Product and service4 records
1PolySea™ Topicals
CategorySeaweed-derived skincare bioactives
Description

Clinically proven PolySea-infused skincare formulations designed to reduce wrinkles, hydrate skin, and restore radiance using seaweed-derived bioactives, intended for cosmetics and skincare brand partners and direct consumer sale.

2PolySea™ Supplements
3PolySea™ Functional Food & Beverages
4PolySea™ Bioactive Ingredient
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1NIS Labs
Strategic tierCoreTypeStrategic or Co-development Partner
Description

NIS Labs, founded by Gitte Jensen, PhD, conducted human clinical trials for SeaChange Biochemistry. 20-participant placebo-controlled, cross-over, randomized, double-blind study with blood draws testing PolySea ingestibles for antioxidant protection, immune alertness, and stem cell activation.

seachangebiochemistry.com
Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global nutrition, health, and personal care ingredients major with algae-derived and marine-source bioactives. Competes for the same cosmetic and nutraceutical customers as SeaChange, albeit across a much broader ingredient portfolio.

TypeDirect peer
Description

France-based seaweed extract producer supplying alginates, fucoidans, and bioactive fractions to food, nutrition, and personal care brands. Closely parallels SeaChange's seaweed-derived bioactive ingredient model and customer base.

TypeDirect peer
Description

Australian specialty ingredient company producing high-purity fucoidan and polyphenol extracts from wild and cultivated seaweed for nutraceutical, cosmetic, and functional food applications — directly comparable to SeaChange's PolySea offering in both technology and end markets.

TypeBroad incumbent
Description

Global leader in hydrocolloids including alginate and specialty biopolymers. Comparable as a supplier of seaweed-derived functional ingredients to food, beverage, and personal care manufacturers, but at significantly larger scale and broader portfolio.

TypeDirect peer
Description

Canadian marine plant processor (Nova Scotia-headquartered) producing seaweed extracts for agriculture, food, and personal care. Direct peer given shared Nova Scotia sourcing origin and overlapping B2B ingredient customer segments.

TypeBroad incumbent
Description

Global taste and nutrition company supplying functional ingredients (including marine-sourced proteins and extracts) to F&B and supplement customers. Comparable as an incumbent B2B ingredient supplier serving the same functional wellness end markets.

TypeDirect peer
Description

Ireland-based producer of seaweed-based ingredient blends for animal nutrition and human functional foods. Comparable ingredient supplier targeting B2B nutrition customers, though with a different seaweed feedstock portfolio.

TypeDirect peer
Description

Italian seaweed ingredient supplier (now part of Apulia Group) producing extracts and meals for agriculture, food, and cosmetics. Comparable B2B seaweed ingredient model, although broader and more commodity-oriented.

TypeBroad incumbent
Description

Large diversified ingredient supplier with a portfolio that includes seaweed-derived hydrocolloids, gelling agents, and food/beverage functional ingredients. Comparable as an incumbent competing for the same B2B accounts that SeaChange targets.

TypeDirect peer
Description

Norwegian supplier of marine-derived bioactive ingredients (including fucoidan) for cosmetics and nutraceuticals. Comparable to SeaChange on technology (cold-process extraction) and target markets.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SeaChange Biochemistry

Seaweed-Derived Bioactive Ingredient Manufacturingseachangebiochemistry.com

SeaChange Biochemistry is a Halifax-based biotech company that extracts clinically validated bioactive compounds from sustainably wild-harvested Nova Scotia seaweed using its proprietary SeaQuence™ green chemistry process, supplying PolySea™ ingredients to cosmetics, nutraceutical, and functional food and beverage brands.

What SeaChange Biochemistry does

SeaChange Biochemistry is a Halifax, Canada-based ingredient biotechnology company founded in 2020 that develops and supplies clinically validated, seaweed-derived bioactive compounds for the wellness, cosmetics, nutraceutical, and functional food and beverage industries. The company operates a proprietary, patent-pending extraction platform called SeaQuence™, which uses green chemistry principles and CO2 freeze drying to sequentially extract polyphenols, fucoidan, beta-glucans, and stem cell activators from organic wild-harvested Nova Scotia seaweed — reportedly eliminating up to 90% of the waste generated by conventional solvent-based extraction methods. Its flagship product brand, PolySea™, is positioned as a clinically proven anti-aging and immune-support ingredient available in three application formats: topicals, supplements, and functional food and beverage ingredients, with future pipeline ingredients including Fucoidan, Alginate, and PolySea™ Bioplastics targeting pharmaceutical and sustainable packaging markets.

The company has completed two human clinical trials through a research partnership with NIS Labs — a 20-participant placebo-controlled, randomized, double-blind, cross-over study for ingestibles and a 60-participant 9-week study for topicals in women aged 30-50 — producing quantifiable claims including 8X antioxidant activity versus leading extracts, 10X antioxidant power versus elderberry, 23% reduction in fine lines, 37% reduction in wrinkles, 48% increase in skin hydration, and rapid immune activation within 1-2 hours of consumption. The business model is primarily B2B enterprise field sales to cosmetics brands, nutraceutical companies, and functional food and beverage manufacturers under quote-based multi-year contracts, supplemented by a direct-to-consumer channel selling finished PolySea products through the company website. The company is founder-led by CEO Sabrena MacKenzie, a marine scientist and biochemist, with 1-10 employees and minimal disclosed external capital (a $25,000 Ocean Startup Project grant in 2020 and an undisclosed follow-on grant in 2021).

SeaChange Biochemistry firmographics

Firmographics
Name
SeaChange Biochemistry
Legal name
SeaChange Biochemistry
Website
https://seachangebiochemistry.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Short description
SeaChange Biochemistry is a Halifax-based biotech company that extracts clinically validated bioactive compounds from sustainably wild-harvested Nova Scotia seaweed using its proprietary SeaQuence™ green chemistry process, supplying PolySea™ ingredients to cosmetics, nutraceutical, and functional food and beverage brands.
Ownership category
akta.pro rank

SeaChange Biochemistry industry classification

Industry
Product category
Seaweed-Derived Bioactive Ingredient Manufacturing
akta.pro industry
PRIMARYAFAJAMAD
Seaweed Hydrocolloids (Agar, Carrageenan, Alginates)
Agriculture & Food Production/Food Ingredients & Additives/Texturizers (Thickeners & Stabilizers)
SECONDARYAFAJAHAF
Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)
SECONDARYIMANANAD
Compostable & Bio-based Rigid Packaging (injection/blow/thermoform)

Keywords

  • Seaweed bioactive extraction
  • Natural ingredient manufacturing
  • Cosmetics ingredient supply
  • Nutraceutical ingredient supply
  • Green chemistry extraction

Where SeaChange Biochemistry is headquartered

Location

Headquarters

HQ city
Halifax
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

SeaChange Biochemistry business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales

Revenue model

  1. B2B Bioactive Ingredient Sales: Supply of PolySea™ bioactive ingredients to cosmetics, skincare, nutraceutical, and functional food & beverage manufacturers for use in their products.
  2. Contract Manufacturing / White-label: Provides clinically proven seaweed bioactives that can be incorporated into partner brand formulations, with B2B partnership model for co-development.
  3. Finished Product Sales (Direct-to-Consumer): Sale of PolySea-infused topical and ingestible wellness products directly to consumers through website and potentially retail channels.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractB2B ingredient pricing - quote-based

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

SeaChange Biochemistry product offering

Product offering

Core offering

SeaChange Biochemistry extracts clinically validated bioactive compounds (polyphenols, fucoidan, beta-glucans, stem cell activators) from sustainably wild-harvested Nova Scotia seaweed using its proprietary patent-pending SeaQuence™ green-chemistry process and large-scale CO2 freeze drying. It supplies the resulting PolySea™ bioactive ingredients on a B2B basis to cosmetics/skincare brands, nutraceutical/ supplement manufacturers, and functional food & beverage companies, and also sells PolySea-infused topical and ingestible wellness products direct to consumers.

Product overview

SeaChange Biochemistry offers PolySea™ as its core bioactive ingredient brand derived from organic wild-harvested Nova Scotia seaweed. The product portfolio spans three main application formats: PolySea™ Topicals (advanced skincare), PolySea™ Supplements (cellular wellness and immune support), and PolySea™ Functional Food & Beverages (nutritional applications). The proprietary SeaQuence™ Process serves as the extraction and manufacturing platform enabling all product lines. Future pipeline ingredients include Fucoidan, Alginate, and Bioplastics. All products are positioned for B2B wellness partners including cosmetic brands, nutraceutical companies, and functional food manufacturers.

Differentiator

Problem solved

Functional benefit

Brands

  • PolySea™: The company's flagship seaweed-derived bioactive ingredient line, clinically proven for anti-aging, immune support, and skin health benefits.
  • SeaQuence™

Products and services

  • PolySea™ Topicals Clinically proven PolySea-infused skincare formulations designed to reduce wrinkles, hydrate skin, and restore radiance using seaweed-derived bioactives, intended for cosmetics and skincare brand partners and direct consumer sale.
  • PolySea™ Supplements
  • PolySea™ Functional Food & Beverages
  • PolySea™ Bioactive Ingredient

Quantifiable outcome

  • 8X stronger antioxidant activity than leading extracts
  • +8 more outcomes

Companies that use SeaChange Biochemistry

Customer profile

Segments4 records

Ideal customer profiles4 records

SeaChange Biochemistry technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

SeaChange Biochemistry partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • NIS LabscoreStrategic or Co-development PartnerNIS Labs, founded by Gitte Jensen, PhD, conducted human clinical trials for SeaChange Biochemistry. 20-participant placebo-controlled, cross-over, randomized, double-blind study with blood draws testing PolySea ingestibles for antioxidant protection, immune alertness, and stem cell activation.

Scale indicators4 records

Recent moves3 records

Expansion highlights6 records

SeaChange Biochemistry competitors and assessment

Company assessment

Broad incumbents

  • dsm-firmenich: Global nutrition, health, and personal care ingredients major with algae-derived and marine-source bioactives. Competes for the same cosmetic and nutraceutical customers as SeaChange, albeit across a much broader ingredient portfolio.
  • CP Kelco: Global leader in hydrocolloids including alginate and specialty biopolymers. Comparable as a supplier of seaweed-derived functional ingredients to food, beverage, and personal care manufacturers, but at significantly larger scale and broader portfolio.
  • Kerry Group: Global taste and nutrition company supplying functional ingredients (including marine-sourced proteins and extracts) to F&B and supplement customers. Comparable as an incumbent B2B ingredient supplier serving the same functional wellness end markets.
  • IFF (Health & Biosciences / DuPont N&B legacy): Large diversified ingredient supplier with a portfolio that includes seaweed-derived hydrocolloids, gelling agents, and food/beverage functional ingredients. Comparable as an incumbent competing for the same B2B accounts that SeaChange targets.

Direct peers

  • Algaia: France-based seaweed extract producer supplying alginates, fucoidans, and bioactive fractions to food, nutrition, and personal care brands. Closely parallels SeaChange's seaweed-derived bioactive ingredient model and customer base.
  • Marinova: Australian specialty ingredient company producing high-purity fucoidan and polyphenol extracts from wild and cultivated seaweed for nutraceutical, cosmetic, and functional food applications — directly comparable to SeaChange's PolySea offering in both technology and end markets.
  • Acadian Seaplants: Canadian marine plant processor (Nova Scotia-headquartered) producing seaweed extracts for agriculture, food, and personal care. Direct peer given shared Nova Scotia sourcing origin and overlapping B2B ingredient customer segments.
  • Ocean Harvest Technology: Ireland-based producer of seaweed-based ingredient blends for animal nutrition and human functional foods. Comparable ingredient supplier targeting B2B nutrition customers, though with a different seaweed feedstock portfolio.
  • Algea: Italian seaweed ingredient supplier (now part of Apulia Group) producing extracts and meals for agriculture, food, and cosmetics. Comparable B2B seaweed ingredient model, although broader and more commodity-oriented.
  • Seagarden: Norwegian supplier of marine-derived bioactive ingredients (including fucoidan) for cosmetics and nutraceuticals. Comparable to SeaChange on technology (cold-process extraction) and target markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

SeaChange Biochemistry social profiles

Digital presence

SeaChange Biochemistry financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SeaChange Biochemistry leadership team

Management profile

Number of profiles

Profiles1 record

SeaChange Biochemistry funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SeaChange Biochemistry M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SeaChange Biochemistry

What does SeaChange Biochemistry do?

SeaChange Biochemistry extracts clinically validated bioactive compounds (polyphenols, fucoidan, beta-glucans, stem cell activators) from sustainably wild-harvested Nova Scotia seaweed using its proprietary patent-pending SeaQuence™ green-chemistry process and large-scale CO2 freeze drying. It supplies the resulting PolySea™ bioactive ingredients on a B2B basis to cosmetics/skincare brands, nutraceutical/ supplement manufacturers, and functional food & beverage companies, and also sells PolySea-infused topical and ingestible wellness products direct to consumers.

Is SeaChange Biochemistry a public or private company?

SeaChange Biochemistry is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was SeaChange Biochemistry founded?

SeaChange Biochemistry was founded in 2020. It employs 1 to 10 people.

Where is SeaChange Biochemistry based?

SeaChange Biochemistry is headquartered in Halifax, Canada, in the North America region.

How does SeaChange Biochemistry make money?

Three revenue lines are on record. B2B Bioactive Ingredient Sales are the primary driver. The others are contract Manufacturing / White-label and finished Product Sales (Direct-to-Consumer).

Who are SeaChange Biochemistry's main competitors?

Broad incumbents on record are dsm-firmenich, CP Kelco, Kerry Group and IFF (Health & Biosciences / DuPont N&B legacy). Direct peers are Algaia, Marinova, Acadian Seaplants, Ocean Harvest Technology, Algea and Seagarden.

Does SeaChange Biochemistry have an API?

No public API is recorded for SeaChange Biochemistry.

What industry is SeaChange Biochemistry in?

SeaChange Biochemistry's product category is Seaweed-Derived Bioactive Ingredient Manufacturing. Its primary akta.pro industry code is AFAJAMAD, Seaweed Hydrocolloids (Agar, Carrageenan, Alginates), with a secondary code of AFAJAHAF, Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals